Is there a role for carbohydrate restriction in the treatment and prevention of cancer
Reads0
Chats0
TLDR
The possible beneficial effects of low CHO diets on cancer prevention and treatment are addressed, with emphasis on the role of insulin and IGF1 signaling in tumorigenesis as well as altered dietary needs of cancer patients.Abstract:
Over the last years, evidence has accumulated suggesting that by systematically reducing the amount of dietary carbohydrates (CHOs) one could suppress, or at least delay, the emergence of cancer, and that proliferation of already existing tumor cells could be slowed down. This hypothesis is supported by the association between modern chronic diseases like the metabolic syndrome and the risk of developing or dying from cancer. CHOs or glucose, to which more complex carbohydrates are ultimately digested, can have direct and indirect effects on tumor cell proliferation: first, contrary to normal cells, most malignant cells depend on steady glucose availability in the blood for their energy and biomass generating demands and are not able to metabolize significant amounts of fatty acids or ketone bodies due to mitochondrial dysfunction. Second, high insulin and insulin-like growth factor (IGF)-1 levels resulting from chronic ingestion of CHO-rich Western diet meals, can directly promote tumor cell proliferation via the insulin/IGF1 signaling pathway. Third, ketone bodies that are elevated when insulin and blood glucose levels are low, have been found to negatively affect proliferation of different malignant cells in vitro or not to be usable by tumor cells for metabolic demands, and a multitude of mouse models have shown antitumorigenic properties of very low CHO ketogenic diets. In addition, many cancer patients exhibit an altered glucose metabolism characterized by insulin resistance and may profit from an increased protein and fat intake. In this review, we address the possible beneficial effects of low CHO diets on cancer prevention and treatment. Emphasis will be placed on the role of insulin and IGF1 signaling in tumorigenesis as well as altered dietary needs of cancer patients.read more
Citations
More filters
Journal ArticleDOI
The Effects of Leucine on Mitochondrial Biogenesis and Cell Cycle in A-375 Melanoma Cells
TL;DR: In this article, leucine was shown to stimulate mitochondrial biogenesis and exit from cell cycle in A-375 melanoma cells under both standard (11.1 mM) and reduced (5.5 mM) glucose conditions.
Journal ArticleDOI
Hyperinsulinemia and Insulin Resistance: Scope of the Problem
Jason Fung,Amy L. Berger +1 more
TL;DR: In the 21st century, acute infectious diseases have been replaced by cardiovascular disease (CVD), cancer and diabetic complications as the most common causes of death.
Journal ArticleDOI
Weight change therapy as a potential treatment for end-stage ovarian carcinoma.
Kuat Oshakbayev,Ken Alibek,Igor Olegovich Ponomarev,Nurlybek Nurlanovich Uderbayev,Bibazhar Dukenbayeva +4 more
TL;DR: An analgesic effect was also achieved without use of narcotic or non-narcotic analgesics in a 41-year-old women using weight loss therapy, and ovarian cancer was transformed into smaller-sized ovarian cysts.
Journal ArticleDOI
Recent developments and application of metabolomics in cancer diseases
TL;DR: The latest developments in analytical methods, application of data analysis, investigation of useful databases and the curent application of metabolomics in cancer diseases that have led to the identification of related biomarkers are discussed.
Journal ArticleDOI
Preliminary investigation of blood concentrations of insulin-like growth factor, insulin, lactate and β-hydroxybutyrate in dogs with lymphoma as compared with matched controls.
TL;DR: This preliminary study suggests that higher insulin and IGF-1 levels relative to controls may not be a consistent finding in dogs with lymphoma, and the significance of increased β-hydroxybutyrate in dogsWith lymphoma warrants further investigation in a larger prospective study.
References
More filters
Journal ArticleDOI
Hallmarks of cancer: the next generation.
TL;DR: Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.
Journal ArticleDOI
Cancer-related inflammation.
TL;DR: The molecular pathways of this cancer-related inflammation are now being unravelled, resulting in the identification of new target molecules that could lead to improved diagnosis and treatment.
Journal ArticleDOI
Why do cancers have high aerobic glycolysis
TL;DR: In this article, the authors propose that persistent metabolism of glucose to lactate even in aerobic conditions is an adaptation to intermittent hypoxia in pre-malignant lesions, which leads to microenvironmental acidosis requiring evolution to phenotypes resistant to acid-induced cell toxicity.
Journal ArticleDOI
Extending Healthy Life Span-From Yeast to Humans
TL;DR: Dietary restriction and reduced activity of nutrient-sensing pathways may slow aging by similar mechanisms, which have been conserved during evolution, and their potential application to prevention of age-related disease and promotion of healthy aging in humans, and the challenge of possible negative side effects.